The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers.
Vlad Constantin DonicaAnisia Iuliana AlexaIrina Andreea PavelCiprian DanielescuManuela Andreea CiapăAlexandra Lori DonicaCamelia-Margareta BogdaniciPublished in: Biomedicines (2023)
The prevalence of multiple sclerosis (MS) has been increasing among young people in developing countries over the last years. With the continuous development of new technology, the diagnosis and follow-up of these patients has received new parameters that physicians may use in their practice. This paper reviews the main biomarkers identified through Optical Coherence Tomography Angiography (OCT-A) involved in the development and progression of MS and investigates the role it may have in detecting changes to the central nervous system (CNS).
Keyphrases
- multiple sclerosis
- optical coherence tomography
- primary care
- end stage renal disease
- diabetic retinopathy
- white matter
- mass spectrometry
- ejection fraction
- newly diagnosed
- healthcare
- chronic kidney disease
- ms ms
- prognostic factors
- risk factors
- peritoneal dialysis
- randomized controlled trial
- systematic review
- blood brain barrier
- cerebrospinal fluid
- patient reported
- patient reported outcomes